| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $1.54B | +0.5% |
| Cost of Revenue | $599.7M | +9.9% |
| Gross Profit | $942.0M | -4.7% |
| R&D Expense | $177.3M | +5.5% |
| SG&A Expense | $275.1M | +42.0% |
| Operating Income | $310.8M | -32.0% |
| Pre-tax Income | $313.8M | -27.2% |
| Income Tax | $80.2M | -32.3% |
| Net Income | $233.6M |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $359.1M | -60.7% |
| Accounts Receivable | $358.6M | +11.6% |
| Inventory | $64.7M | -4.9% |
| Current Assets | $900.0M | -32.2% |
| Total Assets | $2.23B | +12.5% |
| Current Liabilities | $333.4M | +38.6% |
| Long-term Debt | $568.7M | +0.6% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $390.1M | -28.4% |
| Capital Expenditures | $36.1M | -30.1% |
| Investing Cash Flow | -$627.2M | -177.5% |
| Financing Cash Flow | -$316.6M | -167.1% |
| Free Cash Flow | $354.1M | -28.2% |
| -25.2% |
| EPS (Basic) | $3.46 | -23.5% |
| EPS (Diluted) | $3.41 | -21.8% |
| Total Liabilities |
| $1.14B |
| +27.5% |
| Stockholders' Equity | $1.09B | +0.2% |